Vedic Medical Astrology in Essential Hypertension: A Double-blind, Placebo-controlled Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 68
- 试验地点
- 1
- 主要终点
- Average systolic and average diastolic blood pressure
研究概览
简要总结
Previous studies have explored the correlation and impact of astrological events in relation of diseases, health concerns and relationship between birth chart and disease risk. Cardiovascular conditions, sleep and fertility were found significantly associated with moon phase. However, to best of our knowledge no study has documented the impact of astrological intervention in disease management.
This is a randomised, multi-center, double blind placebo controlled clinical trial with two parallel arms. This trial aims to evaluate the effectiveness of Vedic medical astrological intervention for patients with mild to moderate hypertension,with respect to decreasing their blood pressure and improving their quality of life.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 35 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients age between 35 and 60 years old, male and female;
- •Patients who meet the diagnostic criteria of essential hypertension (
- •Patients taking antihypertensive drugs under the supervision of physicians.
- •Patients having understanding of our study and willing to comply with astrological protocol.
- •Informed consent
排除标准
- •Patients who have been diagnosed as secondary hypertension or malignant hypertension
- •Patients with comorbid conditions
- •Patients with a chronic disease associated or psychiatric conditions which might not suitable for the study
- •Patients who had been treated with any other alternative or complementary medicine during the previous three months
研究组 & 干预措施
Vedic Medical Astrology Group (VMA)
干预措施: Vedic Medical Astrology (Combination Product)
Placebo vedic medical astrology (PMA)
干预措施: Placebo vedic medical astrology (PMA) (Other)
结局指标
主要结局
Average systolic and average diastolic blood pressure
时间窗: change from baseline to 12-weeks
Blood pressure measured by 24-hour ambulatory blood pressure monitoring
次要结局
- Changes in patients Quality of life(change from baseline to 12-weeks)